Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Carazolol | 57775-29-8 | MFCD00864588 | 99.7% | 298.38 g·mol⁻¹ | C18H22N2O2 | 50 MG
SDP

Catalog No. 5000241498
Encompass_Preferred

Carazolol is a research-grade adrenergic ligand used as a high-potency β1/β2 adrenoceptor antagonist and a potent, selective β3-adrenoceptor agonist. It is intended for use as an analytical standard and reagent in pharmacology and hypertension research. Supporting documents such as a datasheet, certificate of analysis, and safety data sheet are available.

  • High potency β1/β2 adrenoceptor antagonist for receptor studies.
  • Potent, selective β3-adrenoceptor agonist activity.
  • High purity (99.7%) suitable for analytical applications.
  • Supplied in a small research package (50 mg).
  • Supporting documents available: datasheet, COA, SDS.

Catalog No. 50-002-41498 Supplier Medchemexpress LLC Supplier No. HY10732750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Carazolol is a research-grade adrenergic ligand used as a high-potency β1/β2 adrenoceptor antagonist and a potent, selective β3-adrenoceptor agonist. It is intended for use as an analytical standard and reagent in pharmacology and hypertension research. Supporting documents such as a datasheet, certificate of analysis, and safety data sheet are available.

  • High potency β1/β2 adrenoceptor antagonist for receptor studies.
  • Potent, selective β3-adrenoceptor agonist activity.
  • High purity (99.7%) suitable for analytical applications.
  • Supplied in a small research package (50 mg).
  • Supporting documents available: datasheet, COA, SDS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.